These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 37720315)

  • 1. Effect of pro-inflammatory cytokine priming and storage temperature of the mesenchymal stromal cell (MSC) secretome on equine articular chondrocytes.
    Jammes M; Contentin R; Audigié F; Cassé F; Galéra P
    Front Bioeng Biotechnol; 2023; 11():1204737. PubMed ID: 37720315
    [No Abstract]   [Full Text] [Related]  

  • 2. Pro-Inflammatory Cytokine Priming and Purification Method Modulate the Impact of Exosomes Derived from Equine Bone Marrow Mesenchymal Stromal Cells on Equine Articular Chondrocytes.
    Jammes M; Cassé F; Velot E; Bianchi A; Audigié F; Contentin R; Galéra P
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone Marrow MSC Secretome Increases Equine Articular Chondrocyte Collagen Accumulation and Their Migratory Capacities.
    Contentin R; Jammes M; Bourdon B; Cassé F; Bianchi A; Audigié F; Branly T; Velot É; Galéra P
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory licensed equine MSCs are chondroprotective and exhibit enhanced immunomodulation in an inflammatory environment.
    Cassano JM; Schnabel LV; Goodale MB; Fortier LA
    Stem Cell Res Ther; 2018 Apr; 9(1):82. PubMed ID: 29615127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adeno-Associated Virus-Mediated Overexpression of Interleukin-10 Affects the Immunomodulatory Properties of Equine Bone Marrow-Derived Mesenchymal Stem Cells.
    Cameron AD; Even KM; Linardi RL; Berglund AK; Schnabel LV; Engiles JB; Ortved KF
    Hum Gene Ther; 2021 Sep; 32(17-18):907-918. PubMed ID: 33843261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galectin-1 and galectin-3 expression in equine mesenchymal stromal cells (MSCs), synovial fibroblasts and chondrocytes, and the effect of inflammation on MSC motility.
    Reesink HL; Sutton RM; Shurer CR; Peterson RP; Tan JS; Su J; Paszek MJ; Nixon AJ
    Stem Cell Res Ther; 2017 Nov; 8(1):243. PubMed ID: 29096716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoregulatory potential of mesenchymal stem cells following activation by macrophage-derived soluble factors.
    Saldaña L; Bensiamar F; Vallés G; Mancebo FJ; García-Rey E; Vilaboa N
    Stem Cell Res Ther; 2019 Feb; 10(1):58. PubMed ID: 30760316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equine osteoarthritis: Strategies to enhance mesenchymal stromal cell-based acellular therapies.
    Jammes M; Contentin R; Cassé F; Galéra P
    Front Vet Sci; 2023; 10():1115774. PubMed ID: 36846261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in the secretome of tri-dimensional spheroid-cultured human mesenchymal stem cells in vitro by interleukin-1 priming.
    Redondo-Castro E; Cunningham CJ; Miller J; Brown H; Allan SM; Pinteaux E
    Stem Cell Res Ther; 2018 Jan; 9(1):11. PubMed ID: 29343288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of inflammatory environment on equine bone marrow derived mesenchymal stem cells immunogenicity and immunomodulatory properties.
    Barrachina L; Remacha AR; Romero A; Vázquez FJ; Albareda J; Prades M; Ranera B; Zaragoza P; Martín-Burriel I; Rodellar C
    Vet Immunol Immunopathol; 2016 Mar; 171():57-65. PubMed ID: 26964718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential response of mesenchymal stromal cells (MSCs) to type 1 ex vivo cytokine priming: implications for MSC therapy.
    Burnham AJ; Foppiani EM; Goss KL; Jang-Milligan F; Kamalakar A; Bradley H; Goudy SL; Trochez CM; Dominici M; Daley-Bauer L; Gibson G; Horwitz EM
    Cytotherapy; 2023 Dec; 25(12):1277-1284. PubMed ID: 37815775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of the Chondrocyte-Specific Phenotype upon Equine Bone Marrow Mesenchymal Stem Cell Differentiation: Influence of Culture Time, Transforming Growth Factors and Type I Collagen siRNAs on the Differentiation Index.
    Branly T; Contentin R; Desancé M; Jacquel T; Bertoni L; Jacquet S; Mallein-Gerin F; Denoix JM; Audigié F; Demoor M; Galéra P
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29389887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine priming enhances the antifibrotic effects of human adipose derived mesenchymal stromal cells conditioned medium.
    Brizio M; Mancini M; Lora M; Joy S; Zhu S; Brilland B; Reinhardt DP; Farge D; Langlais D; Colmegna I
    Stem Cell Res Ther; 2024 Sep; 15(1):329. PubMed ID: 39334258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effects of secretome derived from mesenchymal stem cells with stigmasterol to negate IL-1β-induced inflammation in-vitro using rat chondrocytes-OA management.
    Sampath SJP; Rath SN; Kotikalapudi N; Venkatesan V
    Inflammopharmacology; 2021 Dec; 29(6):1701-1717. PubMed ID: 34546477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marine Collagen Hydrolysates Downregulate the Synthesis of Pro-Catabolic and Pro-Inflammatory Markers of Osteoarthritis and Favor Collagen Production and Metabolic Activity in Equine Articular Chondrocyte Organoids.
    Bourdon B; Contentin R; Cassé F; Maspimby C; Oddoux S; Noël A; Legendre F; Gruchy N; Galéra P
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33430111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unveiling the functional heterogeneity of cytokine-primed human umbilical cord mesenchymal stem cells through single-cell RNA sequencing.
    Hu Z; Li D; Wu S; Pei K; Fu Z; Yang Y; Huang Y; Yang J; Liu C; Hu J; Cai C; Liao Y
    Cell Biosci; 2024 Mar; 14(1):40. PubMed ID: 38532459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Priming Equine Bone Marrow-Derived Mesenchymal Stem Cells with Proinflammatory Cytokines: Implications in Immunomodulation-Immunogenicity Balance, Cell Viability, and Differentiation Potential.
    Barrachina L; Remacha AR; Romero A; Vázquez FJ; Albareda J; Prades M; Gosálvez J; Roy R; Zaragoza P; Martín-Burriel I; Rodellar C
    Stem Cells Dev; 2017 Jan; 26(1):15-24. PubMed ID: 27712399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine-induced interleukin-1 receptor antagonist protein expression in genetically engineered equine mesenchymal stem cells for osteoarthritis treatment.
    Gabner S; Ertl R; Velde K; Renner M; Jenner F; Egerbacher M; Hlavaty J
    J Gene Med; 2018 May; 20(5):e3021. PubMed ID: 29608232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cells secrete factors that inhibit inflammatory processes in short-term osteoarthritic synovium and cartilage explant culture.
    van Buul GM; Villafuertes E; Bos PK; Waarsing JH; Kops N; Narcisi R; Weinans H; Verhaar JA; Bernsen MR; van Osch GJ
    Osteoarthritis Cartilage; 2012 Oct; 20(10):1186-96. PubMed ID: 22771777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of effectiveness and safety of repeat administration of proinflammatory primed allogeneic mesenchymal stem cells in an equine model of chemically induced osteoarthritis.
    Barrachina L; Remacha AR; Romero A; Vitoria A; Albareda J; Prades M; Roca M; Zaragoza P; Vázquez FJ; Rodellar C
    BMC Vet Res; 2018 Aug; 14(1):241. PubMed ID: 30119668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.